|
19
|
96
|
4z6aL |
Crystal structure of a fviia-trypsin chimera (yt) in complex with soluble tissue factor |
|
12
|
57
|
4yt7L |
Factor viia in complex with the inhibitor 2-(2-{(r)-[(4-carbamimidoylphenyl)amino][5-ethoxy-2-fluoro-3-(propan-2-yloxy)phenyl]methyl}-1h-imidazol-4-yl)benzamide |
|
211
|
551
|
4e1gA |
X-ray crystal structure of alpha-linolenic acid bound to the cyclooxygenase channel of cyclooxygenase-2 |
|
22
|
122
|
4cudA |
Human notch1 egf domains 11-13 mutant fucosylated at t466 |
|
21
|
121
|
4cufA |
Human notch1 egf domains 11-13 mutant t466s |
|
19
|
122
|
4cueA |
Human notch1 egf domains 11-13 mutant t466v |
|
21
|
125
|
4d0fA |
Human notch1 egf domains 11-13 mutant t466a |
|
182
|
552
|
4coxA |
Cyclooxygenase-2 (prostaglandin synthase-2) complexed with a non-selective inhibitor, indomethacin |
|
18
|
132
|
4d90A |
Crystal structure of del-1 egf domains |
|
22
|
122
|
4d0eA |
Human notch1 egf domains 11-13 mutant glcnac-fucose disaccharide modified at t466 |
|
58
|
280
|
4csyA |
E-selectin lectin, egf-like and two scr domains complexed with sialyl lewis x |
|
37
|
326
|
4bxsA |
Crystal structure of the prothrombinase complex from the venom of pseudonaja textilis |
|
69
|
322
|
4bxwA |
Crystal structure of the prothrombinase complex from the venom of pseudonaja textilis |
|
13
|
53
|
4btuA |
Factor xa in complex with the dual thrombin-fxa inhibitor 57. |
|
58
|
280
|
4c16A |
E-selectin lectin, egf-like and two scr domains complexed with glycomimetic antagonist |
|
10
|
53
|
4btiA |
Factor xa in complex with the dual thrombin-fxa inhibitor 58. |
|
11
|
51
|
4bttA |
Factor xa in complex with the dual thrombin-fxa inhibitor 31. |
|
13
|
83
|
4bdxA |
The structure of the fni-egf tandem domain of coagulation factor xii |
|
17
|
83
|
4bdwA |
The structure of the fni-egf tandem domain of coagulation factor xii in complex with holmium |
|
62
|
330
|
3zyiB |
Netring2 in complex with ngl2 |
|
2
|
51
|
4a94C |
Structure of the carboxypeptidase inhibitor from nerita versicolor in complex with human cpa4 |
|
11
|
53
|
4a7iA |
Factor xa in complex with a potent 2-amino-ethane sulfonamide inhibitor |
|
73
|
360
|
4aqtA |
Laminin gamma1 ln-le1-2 structure |
|
63
|
330
|
3zyjB |
Netring1 in complex with ngl1 |
|
76
|
327
|
3zygA |
Netring2 lam and egf1 domains |
|
80
|
341
|
3v64C |
Crystal structure of agrin and lrp4 |
|
71
|
335
|
3v65B |
Crystal structure of agrin and lrp4 complex |
|
205
|
551
|
3tziA |
X-ray crystal structure of arachidonic acid bound in the cyclooxygenase channel of g533v murine cox-2 |
|
19
|
123
|
3u73A |
Crystal structure of stabilized human upar mutant in complex with atf |
|
12
|
54
|
3tk5B |
Factor xa in complex with d102-4380 |
|
12
|
54
|
3tk6B |
Factor xa in complex with d46-5241 |
|
12
|
50
|
3tgfA |
The solution structure of human transforming growth factor alpha |
|
81
|
331
|
3tbdA |
Crystal structure of domain vi and le1 of human netrin-g2 |
|
17
|
96
|
3th3L |
Mg2+ is required for optimal folding of the gamma-carboxyglutamic acid (gla) domains of vitamin k-dependent clotting factors at physiological ca2+ |
|
77
|
305
|
3sobB |
The structure of the first ywtd beta propeller domain of lrp6 in complex with a fab |
|
80
|
306
|
3sovA |
The structure of a beta propeller domain in complex with peptide s |
|
80
|
305
|
3soqA |
The structure of the first ywtd beta propeller domain of lrp6 in complex with a dkk1 peptide |
|
46
|
290
|
3s6xA |
Structure of reovirus attachment protein sigma1 in complex with alpha-2,3-sialyllactose |
|
193
|
552
|
3rr3A |
Structure of (r)-flurbiprofen bound to mcox-2 |
|
65
|
298
|
2wzpP |
Structures of lactococcal phage p2 baseplate shed light on a novel mechanism of host attachment and activation in siphoviridae |
|
174
|
553
|
2oyeP |
Indomethacin-(r)-alpha-ethyl-ethanolamide bound to cyclooxygenase-1 |
|
117
|
636
|
1l5gB |
Crystal structure of the extracellular segment of integrin avb3 in complex with an arg-gly-asp ligand |
|
200
|
551
|
5ikrA |
The structure of mefenamic acid bound to human cyclooxygenase-2 |
|
12
|
52
|
4zh8B |
Factor xa complex with gtc000006 |
|
10
|
51
|
5jbaE |
Crystal structure of factor ixa variant v16i k98t y177t i212v in complex with ppack |
|
12
|
55
|
4zxyL |
Factor viia in complex with the inhibitor (2r)-2-[(1-aminoisoquinolin-6-yl)amino]-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione |
|
13
|
55
|
5i46L |
Factor viia in complex with the inhibitor (2r,15r)-2-[(1-aminoisoquinolin-6-yl)amino]-8-fluoro-7-hydroxy-4,15,17-trimethyl-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaene-3,12-dione |
|
11
|
55
|
4zxxL |
Factor viia in complex with the inhibitor n-{3-[(2r)-1-{(2r)-2-[(1-aminoisoquinolin-6-yl)amino]-2-phenylacetyl}pyrrolidin-2-yl]-4-(propan-2-ylsulfonyl)phenyl}acetamide |
|
195
|
551
|
4z0lA |
The murine cyclooxygenase-2 complexed with a nido-dicarbaborate-containing indomethacin derivative |
|
12
|
55
|
4z0kB |
Rapid development of two factor ixa inhibitors from hit to lead |
